Supplement

See all supplements

Human papillomavirus

Vol. 488 No. 7413_supp ppS1-S48
  • In this Supplement

  • It is tempting to characterize the human papillomavirus (HPV) story as a triumph of science. It might have taken 30 years from identification of HPV as the cause of cervical cancer to the first vaccine reaching the market, but there is still much to understand about HPV biology and an urgent need to improve on existing vaccines and diagnostic tests. The story of HPV is still being written.

    Cover Art: Nik Spencer

Outlook

Top

Collection

Top

Sponsors:

VACTIA - The Center for Vaccine Research and Immunology The Finnish Medical Association PreHdict